Latest in Cardiology from ACC.org

• LAAO in Patients With Prior Intracranial Hemorrhage, Ischemic Stroke Despite OAC, More
  Recent left atrial appendage occlusion (LAAO) research published in JACC: Clinical Electrophysiology and JACC: Advances explores outcomes in patients with prior intracranial hemorrhage (ICH) as well as those with prior ischemic stroke despite oral anticoagulation (OAC) and compares adjudicated registry-reported events with claims data. Two of these studies used data from ACC’s LAAO Registry.
• ACC CardiaCast: 2024 ACC Expert Consensus Decision Pathway for Treatment of HFrEF
  In this episode, Vanessa Blumer, MD, FACC, and Ersilia M. DeFilippis, MD, FACC, discuss the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction (HFrEF).
• ACC Middle East 2025: Virtual Reality Decreases Patient Anxiety During CV Procedures
  Among patients undergoing coronary angiography (CAG), using virtual reality (VR) during the procedure relieved anxiety and promoted more stable vital signs, according to research presented during the ACC Middle East 2025 Together with 16th Emirates Cardiac Society Conference, held in Dubai, UAE.
• ACC Middle East 2025: CVD Risk Increases the Longer Immigrants Live in the US
  New immigrants to the U.S. have a lower prevalence of cardiovascular disease risk factors than individuals born in the U.S., but these risk factors increase the longer they live in the U.S., a so-called "healthy immigrant effect," according to research presented during the ACC Middle East 2025 Together with 16th Emirates Cardiac Society Conference, held […]
• ASSET-IT: Early Tirofiban Increases Functional Outcomes For Noncardioembolic Stroke
  Early tirofiban significantly improved the likelihood of disability-free and functionally independent outcomes in patients with acute ischemic noncardioembolic stroke who receive thrombolysis within 4.5 hours after onset, according to results from the phase 3 ASSET-IT trial, published July 3 in NEJM.